Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Teneligliptin HCL I.P. 20mg + Metformin HCL I.P. 1000mg Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹179/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tengroup M Forte Tablet combines Teneligliptin 20mg, a selective DPP-4 inhibitor, with Metformin 1000mg, a widely used biguanide antidiabetic agent, in a single formulation designed for enhanced blood glucose control in type 2 diabetes mellitus. Teneligliptin improves the body’s ability to regulate blood sugar by increasing incretin hormone levels, which boost insulin secretion and reduce glucagon release in response to meals. Metformin lowers glucose production by the liver and improves insulin sensitivity in muscle and fat tissues. This powerful combination provides effective management of hyperglycemia with a low risk of hypoglycemia and is suitable for patients who require intensified treatment to achieve optimal glycemic control. Tenelit M Forte supports lifestyle changes such as diet and exercise for comprehensive diabetes care.
May include gastrointestinal symptoms like nausea, diarrhea, or abdominal discomfort primarily due to Metformin. Teneligliptin is generally well tolerated; however, some patients may experience headache or upper respiratory tract symptoms. Hypoglycemia risk remains low but may increase with concomitant use of other antidiabetic agents.
Indicated for the treatment of type 2 diabetes mellitus when monotherapy is insufficient or when dual therapy with Teneligliptin and Metformin is warranted to improve glycemic control.
Not suitable for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Regular monitoring of kidney function and blood sugar levels is essential. Use with caution in hepatic impairment. Consult healthcare professionals before use during pregnancy or breastfeeding.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Teneligliptin 20mg + Metformin Hydrochloride 1000mg Tablet has strong demand in the diabetology, endocrinology, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and chronic care portfolios.
Medical distributors and agencies can benefit from consistent demand for Type 2 diabetes management under medical supervision. Teneligliptin 20mg is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances incretin hormone activity, promoting glucose-dependent insulin secretion and reducing glucagon release Metformin Hydrochloride 1000mg is a biguanide anti-diabetic agent that reduces hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose utilization This combination provides complementary mechanisms of action to help control fasting and postprandial blood glucose levels in adults with Type 2 Diabetes Mellitus, along with a healthy diet and regular exercise Commonly prescribed for patients whose blood glucose levels are not adequately controlled with monotherapy, helping achieve improved glycemic control and reduce the risk of long-term diabetes-related complications Oral tablet formulation supports convenient daily administration and improves treatment adherence when taken as prescribed by the healthcare professional Requires regular monitoring of blood glucose, HbA1c, kidney function, and overall metabolic status during therapy. The medicine should be used only under medical supervision and is not indicated for Type 1 Diabetes Mellitus or diabetic ketoacidosis Frequently utilized in diabetology clinics, endocrinology departments, general medicine practices, and hospitals Widely prescribed by diabetologists, endocrinologists, and general physicians for long-term management of Type 2 Diabetes Mellitus This strengthens a comprehensive anti-diabetic and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Teneligliptin 20mg + Metformin Hydrochloride 1000mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, expanding diabetes care market opportunities, long-term therapy requirements, reliable supply chain support, repeat business, and attractive margins in the anti-diabetic segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality anti-diabetic pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.